Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

Chugai

Chugai Pharmaceutical (Roche, majority owner)

Rank: 29

Tokyo, Japan
www.chugai-pharm.co.jp

2020 Revenues ($USD) : $7,369,357,558
2020 Revenues (foreign currencies) : JP¥786,900,000,000
2020 R&D spend : not available
2020 Number of Employees : 7,555
Fiscal Year End : 12/31/2020
Key People : Osamu Okuda, CEO

Under a strategic alliance forged with Roche in 2002, Chugai maintained management independence while gaining the exclusive right to market Roche's products in Japan. Chugai also has access to the Roche Group's research infrastructure and global platform. Chugai boasts unique antibody engineering technologies as it continues to refine its scientific and technological strengths. –CN

Chugai

Chugai is headquartered in Tokyo.

Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50